Flevoziekenhuis
About Flevoziekenhuis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
15
Maastricht University Medical Center
5
Amsterdam UMC, location VUmc
4
Stichting Hemato-Oncologie voor Volwassenen Nederland
4
Bayer
3
Dutch Colorectal Cancer Group
3
Radboud University Medical Center
2
Ramon Gorter
2
The Netherlands Cancer Institute
2
B.C. van Jaarsveld
1
Borstkanker Onderzoek Groep
1
Clinical Trials at Flevoziekenhuis
During the past decade, Flevoziekenhuis conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 2 clinical trials were completed, i.e. on
average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 1 clinical trials were completed. i.e. 7.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Alpha Omega Trial: Study of Omega-3 Fatty Acids and Coronary Mortality
2002-04-01
2010-06-01
Completed
4,837
Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity
2007-06-01
2014-12-01
Completed
210
Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism
2010-08-01
2014-07-01
Terminated
56
The CHIPS Trial (Control of Hypertension In Pregnancy Study)
2009-04-01
2014-02-01
Completed
987
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
2011-01-01
2023-04-01
Unknown status
1,503
A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer
2010-10-01
2015-07-01
Completed
274
Current Dutch Practice on Caesarean Sections: Identification of Barriers and Facilitators for Optimal Care
2010-12-01
Unknown status
1,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Flevoziekenhuis" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 15 trials, followed by "Maastricht University Medical Center" with 5 trials
sponsored, "Amsterdam UMC, location VUmc" with 4 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 4 trials sponsored and "Bayer"
with 4 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 27 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Flevoziekenhuis"
#1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 11 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 6 trials as a collaborator, "Flevoziekenhuis" with 6 trials as a collaborator, "Amsterdam UMC, location VUmc" with 4 trials as a collaborator and "Borstkanker Onderzoek Groep" with 4 trials as a collaborator. Other collaborators include 97 different institutions and companies that were
collaborators in the rest 85 trials.
Clinical Trials Conditions at Flevoziekenhuis
According to Clinical.Site data, the most researched conditions in "Flevoziekenhuis" are
"Colorectal Cancer" (4 trials), "Appendicitis" (3 trials), "Breast Neoplasms" (2 trials), "Kidney Failure, Chronic" (2 trials) and "Neoplasms" (2 trials). Many other conditions were trialed in "Flevoziekenhuis" in a lesser frequency.
Clinical Trials Intervention Types at Flevoziekenhuis
Most popular intervention types in "Flevoziekenhuis" are "Drug" (25 trials), "Procedure" (14 trials), "Other" (12 trials), "Device" (6 trials) and "Behavioral" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Appendectomy" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials), "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials) and "AT1 blocker candesartan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Flevoziekenhuis
The vast majority of trials in "Flevoziekenhuis" are
44 trials for "All" genders, 13 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Flevoziekenhuis
Currently, there are NaN active trials in "Flevoziekenhuis".
undefined are not yet recruiting,
18 are recruiting,
11 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 13 completed trials in Flevoziekenhuis,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Flevoziekenhuis, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 21 trials that are defined as “Not Applicable".